Meldonium

Half-Life (t½)
IV: 6.46h
Formula
C6H14N2O2
Molecular Weight
146.19 g/mol
PubChem CID
123868
Aliases
mildronate, Mildronate, MET-88, THP, quaterine

Pharmacological Mechanism

Structural analogue of gamma-butyrobetaine and an inhibitor of gamma-butyrobetaine hydroxylase, the last enzyme of carnitine biosynthesis. Lowering carnitine limits long-chain fatty-acid transport into mitochondria and shifts myocardial and neural metabolism toward glucose oxidation, which needs less oxygen per ATP — the basis of its anti-ischaemic use and of the cognitive/anti-fatigue claims made for it in the territories where it is marketed. Banned by WADA since 2016.

Half-Life & Elimination Curve (IV: 6.46h)

100%50%25%12.5%0%0h0×t½6.46h1×t½12.9h2×t½19.4h3×t½25.8h4×t½32.3h5×t½0×t½ (0h): 100% remaining1×t½ (6.46h): 50% remaining2×t½ (12.9h): 25% remaining3×t½ (19.4h): 12.5% remaining4×t½ (25.8h): 6.3% remaining5×t½ (32.3h): 3.1% remaining
Elimination (IV)
  • 0×t½0h100%
  • 1×t½6.46h50%
  • 2×t½12.9h25%
  • 3×t½19.4h12.5%
  • 4×t½25.8h6.3%
  • 5×t½32.3h3.1%
Elimination t½6.46h (IV)
Rate Constant (ke)0.107 h⁻¹
97% Washout (5×t½)32.3h

Dosing Guidelines

Pharmacokinetic Parameters

Target Organ Systems

Notes

PubChem CID 123868 (C6H14N2O2). PK: Peng 2010 (PMID:20116348), healthy Chinese volunteers — verbatim "After single intravenously administration of 250, 500 and 1000 mg mildronate, the elimination half-life (t(1/2)) were (5.56+/-1.55), (6.46+/-1.07) and (6.55+/-1.17) h, respectively." The 500 mg arm value is stored as the mid-strength dose; the three arms are close enough that the choice barely matters, but it is a STATED arm rather than a computed average. Multiple-dose IV 500 mg b.i.d. in the same paper gives a longer t½ (15.34+/-3.14 h) with explicit accumulation — that is a different regimen, not a better estimate of the single-dose parameter, so it is not stored. PO IS A DECLARED DANGLING ROUTE: the oral capsule is the common form and the reason the route is listed at all, but no indexed abstract states an oral half-life or bioavailability for meldonium, so authoring PO would mean inventing one. A dose logged against PO renders no curve until that is sourced; logged in AUTHORING_GAPS.md. No volume is published; IV defaults. Indication reference PMID:16007237 ("Mildronate: an antiischemic drug for neurological indications").

Chemical Structure & Identifiers

References